VPCI Release: Spanish Drug Companies Have New Support Option for the U.S. Market

BARCELONA, Spain, July 19, 2011 /PRNewswire/ -- Spanish drug companies face a number of obstacles to commercialize products or technologies in the United States. From regulatory (FDA) and GMP compliance, to distribution agreements and the search for project funding, there are many areas that must be coordinated. Those issues have just become easier to manage as Spanish company KIM and U.S. company VPCI have entered into a joint association. The collaboration will provide Spanish pharmaceutical, biotechnology and medical device companies the necessary support for compliance and commercialization of their products or know-how in the U.S. market.

(Logo: http://photos.prnewswire.com/prnh/20110719/DE35430LOGO )

“This collaboration will provide a unique set of benefits,” said Franco DeVecchi, Jr., Vice President of VPCI. “A Spanish pharmaceutical or medical device company looking to enter the U.S. market can now focus on a single point of contact for support. Our association with KIM allows for local guidance from a project’s conception all the way through commercialization in the U.S. The services of our group have now been greatly expanded and our clients will see immediate benefits.”

The agreements were signed in Washington D.C. during the BIO Washington 2011 conference in which KIM participated jointly with the Catalan delegation led by Biocat. The convention is one of the largest in the international biotechnology sector. KIM’s Healthcare Director, Marti Dalmases said, “We are happy to expand our network of partners. This new agreement is definitely going to help with the arrival in the U.S. of technologies developed in Spain.”

About VPCI

VPCI, Inc. (Vectech Pharmaceutical Consultants International) (www.vpcint.com) is a Pharmaceutical consulting company in the U.S. which offers FDA regulatory guidance, manufacturing technology support and high-level business development services. With scientific and technical experts on a global scale, VPCI has the ability to communicate with clients and regulatory agencies in a number of languages, strictly following good manufacturing practices (GMP).

About KIM

KIM is a service organization located in Barcelona that was formed to improve its clients’ competitiveness and technological progress by offering them specialized services and executing projects related to innovation and transfer of technology and knowledge. KIM’s services include, but are not limited to, project assessment, valuation, commercialization and innovation.

Contact:
VPCI, Inc. (USA)
Franco DeVecchi, Jr., Vice President
Phone: +1 (248) 538-5150
www.vpcint.com
info@vpcint.com

KIM (Spain)
Marti Dalmases, Healthcare Director
Phone: +34 (93) 266 71 38
www.kimbcn.org
mdalmases@kimglobal.com

SOURCE VPCI, Inc.

MORE ON THIS TOPIC